Reversible Senescence in Human CD4+CD45RA+CD27− Memory T Cells
Abstract
Persistent viral infections and inflammatory syndromes induce the accumulation of T cells with characteristics of terminal differentiation or senescence. However, the mechanism that regulates the end-stage differentiation of these cells is unclear. Human CD4+ effector memory (EM) T cells (CD27−CD45RA−) and also EM T cells that re-express CD45RA (CD27−CD45RA+; EMRA) have many characteristics of end-stage differentiation. These include the expression of surface KLRG1 and CD57, reduced replicative capacity, decreased survival, and high expression of nuclear γH2AX after TCR activation. A paradoxical observation was that although CD4+ EMRA T cells exhibit defective telomerase activity after activation, they have significantly longer telomeres than central memory (CM)-like (CD27+CD45RA−) and EM (CD27−CD45RA−) CD4+ T cells. This suggested that telomerase activity was actively inhibited in this population. Because proinflammatory cytokines such as TNF-α inhibited telomerase activity in T cells via a p38 MAPK pathway, we investigated the involvement of p38 signaling in CD4+ EMRA T cells. We found that the expression of both total and phosphorylated p38 was highest in the EM and EMRA compared with that of other CD4+ T cell subsets. Furthermore, the inhibition of p38 signaling, especially in CD4+ EMRA T cells, significantly enhanced their telomerase activity and survival after TCR activation. Thus, activation of the p38 MAPK pathway is directly involved in certain senescence characteristics of highly differentiated CD4+ T cells. In particular, CD4+ EMRA T cells have features of telomere-independent senescence that are regulated by active cell signaling pathways that are reversible.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Unlike cellular senescence in a strict sense, these functional deficits are reversed by inhibiting p38.
“Unlike cellular senescence in a strict sense, these functional deficits are reversed by inhibiting p38”
From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Di Mitri et al., 2011
Unlike senescent fibroblasts, T cells with characteristics of senescence are prone to apoptosis in vitro.
“Unlike senescent fibroblasts however, T cells that have characteristics of senescence are prone to apoptosis in vitro [23, 28] although they may be induced to persist by appropriate signals such as growth factors in vivo [32].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [23]
Senescent-like T cells can be identified by surface marker expression CD27-, CD28-, CD45RA+, KLRG1+, CD57+, which are characteristics of highly differentiated T cells.
“These cells can be identified by surface marker expression (CD27 - ,CD28 - , CD45RA + , KLRG1 + , CD57 + ) that are all characteristics of highly differentiated T cells [23, 28, 30, 31].”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [23]
Within primary human T cells, both CD4+ and CD8+ populations contain a subset of poorly proliferative cells with characteristics very similar to senescent fibroblasts.
“Within primary human T cells, in both CD4 + [23, 28, 29] and CD8 + [25, 30] populations, there is a subset of poorly proliferative cells that exhibit characteristics that are very similar to senescent fibroblasts (Fig. 1).”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [23]
Using small molecule inhibitors or specific inhibitory shRNA, p38 inhibition reconstituted proliferation and telomerase activity in T cells after activation.
“Using small molecule inhibitors [23, 30] or specific inhibitory shRNA [24] it was found that p38 inhibition reconstituted proliferation and also telomerase activity in T cells after activation.”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [23]
Based on in vitro data, blocking agents to p38 could be used in vivo to enhance certain T cell functions.
“One target for reversing senescence in T cells would be the p38 MAP kinase pathway and based on data that has been obtained in vitro , blocking agents to p38 could be used in vivo to enhance certain T cell functions [23-25, 30] .”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [23]
Alterations in T-cell activation in healthy elderly may result from accumulation of memory T cells.
“Alterations in T-cell activation in the healthy elderly may also result from accumulation of memory T cells [143, 144].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [144]
In T cells, what has been called senescence can be reversed by p38 MAP kinase inhibitors.
“However there is evidence, certainly in T cells, that what has been defined as senescence can be reversed with the addition of p38 MAP kinase inhibitors, begging the question if this is proper senescence or indeed if senescence is not always a state of permanent cell cycle arrest (12).”
From The impact of ageing on monocytes and macrophages (2021) · cites this paper as [12]
A block at the level of p38-MAPK by sestrins causes age-related signaling defects in effector and memory CD45RA+/CCR7− T cells.
“For example, a block at the level of p38-MAPK by sestrins causes age-related signaling defects in effector and memory CD45RA+/CCR7− T cells (195, 196).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [195]
The citation lists haven’t been fetched yet
References 72 · Cited by 231
- Authors
- Di Mitri, D., Azevedo, R. I., Henson, S. M., Libri, V., Riddell, N. E., Macaulay, R., Kipling, D., Soares, M. V. D., Battistini, L., & Akbar, A. N.
- Affiliations
- Division of Infection and Immunity, University College London , London W1T 4JF ,
- Instituto de Medicina Molecular João Lobo Antunes (PT)
- University College London (GB)
- Cardiff University (GB)
- Fondazione Santa Lucia (IT)
- Corresponding author
- Libri, Valentina
- Macaulay, Richard
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 187
- Issue
- 5
- Pages
- 2093-2100
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2123799384
- Semantic Scholar
- 01483f552ea150e0e76061c7cbbeebc304ad336c
- Cited by
- 231
- References
- 72
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 24 · 2020: 15 · 2019: 18 · 2018: 9 · 2017: 18 · 2016: 22 · 2015: 11 · 2014: 16 · 2013: 16 · 2012: 15
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council (BB/E019188/1)
- National Institute on Aging (R01AG030327)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- T cell senescence, CD4+ effector memory T cells, telomerase activity, p38 MAPK signaling, TNF-α, T cell survival, KLRG1, CD57, γH2AX, T cell differentiation
- MeSH terms
- Adult, Cell Differentiation, Cell Separation, Flow Cytometry, Humans, Immunologic Memory, Lymphocyte Activation, Middle Aged, Blotting, Western, Signal Transduction, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Cellular Senescence, In Situ Hybridization, Fluorescence, Leukocyte Common Antigens, Tumor Necrosis Factor Receptor Superfamily, Member 7, Telomerase, Reverse Transcriptase Polymerase Chain Reaction, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review